AAPL   329.75 (+2.31%)
FB   231.09 (+2.12%)
GOOGL   1,442.33 (+1.98%)
AMZN   2,476.08 (+0.63%)
NVDA   357.49 (+1.95%)
MU   54.71 (+6.81%)
GE   8.12 (+4.91%)
TSLA   877.01 (+1.46%)
T   32.81 (+3.18%)
ACB   13.96 (-1.90%)
F   7.34 (+11.72%)
GILD   77.00 (-0.70%)
DIS   126.49 (+2.26%)
NFLX   417.60 (+0.79%)
BA   213.27 (+15.72%)
AAPL   329.75 (+2.31%)
FB   231.09 (+2.12%)
GOOGL   1,442.33 (+1.98%)
AMZN   2,476.08 (+0.63%)
NVDA   357.49 (+1.95%)
MU   54.71 (+6.81%)
GE   8.12 (+4.91%)
TSLA   877.01 (+1.46%)
T   32.81 (+3.18%)
ACB   13.96 (-1.90%)
F   7.34 (+11.72%)
GILD   77.00 (-0.70%)
DIS   126.49 (+2.26%)
NFLX   417.60 (+0.79%)
BA   213.27 (+15.72%)
AAPL   329.75 (+2.31%)
FB   231.09 (+2.12%)
GOOGL   1,442.33 (+1.98%)
AMZN   2,476.08 (+0.63%)
NVDA   357.49 (+1.95%)
MU   54.71 (+6.81%)
GE   8.12 (+4.91%)
TSLA   877.01 (+1.46%)
T   32.81 (+3.18%)
ACB   13.96 (-1.90%)
F   7.34 (+11.72%)
GILD   77.00 (-0.70%)
DIS   126.49 (+2.26%)
NFLX   417.60 (+0.79%)
BA   213.27 (+15.72%)
AAPL   329.75 (+2.31%)
FB   231.09 (+2.12%)
GOOGL   1,442.33 (+1.98%)
AMZN   2,476.08 (+0.63%)
NVDA   357.49 (+1.95%)
MU   54.71 (+6.81%)
GE   8.12 (+4.91%)
TSLA   877.01 (+1.46%)
T   32.81 (+3.18%)
ACB   13.96 (-1.90%)
F   7.34 (+11.72%)
GILD   77.00 (-0.70%)
DIS   126.49 (+2.26%)
NFLX   417.60 (+0.79%)
BA   213.27 (+15.72%)
Log in

OTCMKTS:IGXTIntelGenx Technologies News Headlines

$0.21
-0.02 (-8.70 %)
(As of 06/5/2020 12:47 PM ET)
Add
Compare
Today's Range
$0.21
Now: $0.21
$0.23
50-Day Range
$0.17
MA: $0.20
$0.26
52-Week Range
$0.12
Now: $0.21
$0.70
Volume257,602 shs
Average Volume265,617 shs
Market Capitalization$23.15 million
P/E RatioN/A
Dividend YieldN/A
Beta2.28

Headlines

IntelGenx Technologies (OTCMKTS IGXT) News Headlines

Source:
DateHeadline
IntelGenx Technologies Corp. (IGXT)IntelGenx Technologies Corp. (IGXT)
finance.yahoo.com - May 15 at 1:25 PM
IntelGenx Reports First Quarter 2020 Financial ResultsIntelGenx Reports First Quarter 2020 Financial Results
finance.yahoo.com - May 14 at 7:49 PM
IntelGenx (IGXT) Reports Q1 Loss, Tops Revenue EstimatesIntelGenx (IGXT) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 14 at 7:49 PM
IntelGenx Technologies (IGXT) Scheduled to Post Earnings on ThursdayIntelGenx Technologies (IGXT) Scheduled to Post Earnings on Thursday
www.americanbankingnews.com - May 11 at 10:57 AM
IntelGenx to Report First Quarter 2020 Financial Results on May 14, 2020 – Conference Call to FollowIntelGenx to Report First Quarter 2020 Financial Results on May 14, 2020 – Conference Call to Follow
finance.yahoo.com - May 8 at 4:45 PM
Will IntelGenx (IGXT) Report Negative Q1 Earnings? What You Should KnowWill IntelGenx (IGXT) Report Negative Q1 Earnings? What You Should Know
finance.yahoo.com - May 7 at 4:02 PM
IntelGenx Provides Status Update on Cannabis Micro-Processing License ApplicationIntelGenx Provides Status Update on Cannabis Micro-Processing License Application
finance.yahoo.com - April 28 at 8:40 AM
IntelGenx Changes 2020 Annual Meeting of Stockholders to a Virtual-Only FormatIntelGenx Changes 2020 Annual Meeting of Stockholders to a Virtual-Only Format
finance.yahoo.com - April 23 at 7:32 PM
IntelGenx Announces Adjusted VersaFilm® Business Strategy, Next Steps for RIZAPORT® VersaFilm® ProgramIntelGenx Announces Adjusted VersaFilm® Business Strategy, Next Steps for RIZAPORT® VersaFilm® Program
finance.yahoo.com - April 6 at 4:28 PM
IntelGenx Technologies Corp. to Host Earnings CallIntelGenx Technologies Corp. to Host Earnings Call
finance.yahoo.com - March 27 at 9:02 AM
Recap: Intelgenx Technologies Q4 EarningsRecap: Intelgenx Technologies Q4 Earnings
finance.yahoo.com - March 26 at 1:36 PM
IntelGenx EPS beats by $0.01, misses on revenueIntelGenx EPS beats by $0.01, misses on revenue
seekingalpha.com - March 26 at 8:35 AM
IntelGenx Reports Fourth Quarter and Full-Year 2019 Financial ResultsIntelGenx Reports Fourth Quarter and Full-Year 2019 Financial Results
finance.yahoo.com - March 26 at 8:35 AM
IGXT.PQ - IntelGenx Technologies Corp. Profile | ReutersIGXT.PQ - IntelGenx Technologies Corp. Profile | Reuters
www.reuters.com - March 23 at 11:57 PM
INTELGENX TO REPORT FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS ON MARCH 26; CONFERENCE CALL TO FOLLOW ON MARCH 27INTELGENX TO REPORT FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS ON MARCH 26; CONFERENCE CALL TO FOLLOW ON MARCH 27
finance.yahoo.com - March 23 at 8:54 AM
IntelGenx Completes C$8.2 Million Equity OfferingIntelGenx Completes C$8.2 Million Equity Offering
finance.yahoo.com - February 11 at 1:11 PM
IntelGenx prices equity offering at $0.50IntelGenx prices equity offering at $0.50
seekingalpha.com - January 28 at 7:28 AM
IntelGenx Announces Pricing of Equity OfferingIntelGenx Announces Pricing of Equity Offering
finance.yahoo.com - January 27 at 7:41 PM
IntelGenx Receives Health Canada Authorization to Proceed with New Amendment for Montelukast VersaFilm® Phase 2a TrialIntelGenx Receives Health Canada Authorization to Proceed with New Amendment for Montelukast VersaFilm® Phase 2a Trial
finance.yahoo.com - January 15 at 8:17 AM
BRIEF-Intelgenx Enters Animal Health Market By Signing Feasibility Agreement For Vetafilm PlatformBRIEF-Intelgenx Enters Animal Health Market By Signing Feasibility Agreement For Vetafilm Platform
www.msn.com - January 9 at 4:34 PM
IntelGenx Announces Issuance of Shares in Payment of Interest on Outstanding DebenturesIntelGenx Announces Issuance of Shares in Payment of Interest on Outstanding Debentures
finance.yahoo.com - December 13 at 11:56 PM
IntelGenx to Present at the First Annual BioTuesdays Pre-JPM Virtual ConferenceIntelGenx to Present at the First Annual BioTuesdays Pre-JPM Virtual Conference
finance.yahoo.com - December 3 at 9:26 AM
IntelGenx Technologies Corp. (IGXT) CEO Horst Zerbe on Q3 2019 Results - Earnings Call TranscriptIntelGenx Technologies Corp. (IGXT) CEO Horst Zerbe on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 10 at 8:05 AM
IntelGenx to Report Third Quarter 2019 Financial Results on November 7, 2019 – Conference Call to FollowIntelGenx to Report Third Quarter 2019 Financial Results on November 7, 2019 – Conference Call to Follow
finance.yahoo.com - November 1 at 2:14 PM
IntelGenx Initiates Scale-Up Work for Cannabis-Infused Oral Film ProductIntelGenx Initiates Scale-Up Work for Cannabis-Infused Oral Film Product
finance.yahoo.com - October 31 at 6:03 PM
IntelGenx Announces FDA’s Acceptance of Resubmitted RIZAPORT® New Drug ApplicationIntelGenx Announces FDA’s Acceptance of Resubmitted RIZAPORT® New Drug Application
finance.yahoo.com - October 22 at 8:21 AM
IntelGenx Receives Positive DSMB Recommendation for Montelukast VersaFilm® Phase 2a TrialIntelGenx Receives Positive DSMB Recommendation for Montelukast VersaFilm® Phase 2a Trial
finance.yahoo.com - October 9 at 8:45 AM
IntelGenx refiles U.S. application for RizaportIntelGenx refiles U.S. application for Rizaport
seekingalpha.com - September 27 at 9:30 PM
IntelGenx Announces Resubmission of RIZAPORT® New Drug ApplicationIntelGenx Announces Resubmission of RIZAPORT® New Drug Application
finance.yahoo.com - September 26 at 4:48 PM
IntelGenx EPS misses by $0.01, misses on revenueIntelGenx EPS misses by $0.01, misses on revenue
seekingalpha.com - August 9 at 8:59 AM
IntelGenx (IGXT) Reports Q2 Loss, Misses Revenue EstimatesIntelGenx (IGXT) Reports Q2 Loss, Misses Revenue Estimates
finance.yahoo.com - August 8 at 11:40 PM
IntelGenx Reports Second Quarter 2019 Financial ResultsIntelGenx Reports Second Quarter 2019 Financial Results
finance.yahoo.com - August 8 at 6:39 PM
Will IntelGenx (IGXT) Report Negative Q2 Earnings? What You Should KnowWill IntelGenx (IGXT) Report Negative Q2 Earnings? What You Should Know
finance.yahoo.com - August 1 at 6:31 PM
IntelGenx to Report Second Quarter 2019 Financial Results on August 8, 2019 – Conference Call to FollowIntelGenx to Report Second Quarter 2019 Financial Results on August 8, 2019 – Conference Call to Follow
finance.yahoo.com - August 1 at 6:31 PM
IntelGenx to Present at 12th Edition of Clinical Trials on Alzheimer’s DiseaseIntelGenx to Present at 12th Edition of Clinical Trials on Alzheimer’s Disease
finance.yahoo.com - July 10 at 9:36 AM
IntelGenx Announces Addition of Ottawa Montelukast VersaFilm® Phase 2a Clinical Trial Site; First Patient in Study Completes 26-Week TreatmentIntelGenx Announces Addition of Ottawa Montelukast VersaFilm® Phase 2a Clinical Trial Site; First Patient in Study Completes 26-Week Treatment
finance.yahoo.com - June 10 at 10:22 AM
IntelGenx Receives First Shipment of Cannabis Extract from Tilray® for Production of Cannabis-Infused Oral FilmIntelGenx Receives First Shipment of Cannabis Extract from Tilray® for Production of Cannabis-Infused Oral Film
finance.yahoo.com - May 28 at 9:30 AM
IntelGenx to Join the Quebec Pavilion at BIO 2019 International ConventionIntelGenx to Join the Quebec Pavilion at BIO 2019 International Convention
finance.yahoo.com - May 23 at 9:34 AM
IntelGenx Reports First Quarter 2019 Financial ResultsIntelGenx Reports First Quarter 2019 Financial Results
finance.yahoo.com - May 9 at 6:23 PM
IntelGenx and Aquestive Therapeutics Enter Worldwide Collaboration Agreement for TadalafilIntelGenx and Aquestive Therapeutics Enter Worldwide Collaboration Agreement for Tadalafil
finance.yahoo.com - May 8 at 9:32 AM
IntelGenx to Report First Quarter 2019 Financial Results on May 9, 2019 – Conference Call to FollowIntelGenx to Report First Quarter 2019 Financial Results on May 9, 2019 – Conference Call to Follow
finance.yahoo.com - May 2 at 9:40 AM
IntelGenx Announces Issuance of Second U.S. Patent for Topical Oral Film TechnologyIntelGenx Announces Issuance of Second U.S. Patent for Topical Oral Film Technology
finance.yahoo.com - May 1 at 9:23 AM
IntelGenx to Present at the 2019 Bloom Burton & Co. Healthcare Investor ConferenceIntelGenx to Present at the 2019 Bloom Burton & Co. Healthcare Investor Conference
finance.yahoo.com - April 25 at 9:35 AM
IntelGenx to Promote Oral Films CDMO Services at CPhI North AmericaIntelGenx to Promote Oral Films CDMO Services at CPhI North America
finance.yahoo.com - April 23 at 9:33 AM
IntelGenx Files Non-Provisional U.S. Patent Application for Oil-Based Active IngredientsIntelGenx Files Non-Provisional U.S. Patent Application for Oil-Based Active Ingredients
finance.yahoo.com - April 16 at 10:22 AM
IntelGenx Presents at 14th International Conference on Alzheimer’s and Parkinson’s DiseaseIntelGenx Presents at 14th International Conference on Alzheimer’s and Parkinson’s Disease
finance.yahoo.com - April 4 at 9:42 AM
IntelGenx Receives Complete Response Letter from FDA for RIZAPORT® NDAIntelGenx Receives Complete Response Letter from FDA for RIZAPORT® NDA
finance.yahoo.com - April 2 at 11:54 AM
IntelGenx Reports Fourth Quarter and Full-Year 2018 Financial ResultsIntelGenx Reports Fourth Quarter and Full-Year 2018 Financial Results
finance.yahoo.com - March 22 at 6:06 PM
CORRECTION - IntelGenx to Report Fourth Quarter and Full-Year 2018 Financial Results on March 22, ...CORRECTION - IntelGenx to Report Fourth Quarter and Full-Year 2018 Financial Results on March 22, ...
www.globenewswire.com - March 18 at 6:29 PM
IntelGenx to Report Fourth Quarter and Full-Year 2018 Financial Results on March 25, 2019 – Conference Call to FollowIntelGenx to Report Fourth Quarter and Full-Year 2018 Financial Results on March 25, 2019 – Conference Call to Follow
finance.yahoo.com - March 18 at 6:29 PM
This page was last updated on 6/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.